Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2300078799Phase 4Recruiting
Phase 4, randomised trial of oxycodone in endometrial polyp and Fibromyoma (LM) (2 arms), sponsored by Weifang Maternal and Child Health Care Hospital. Primary endpoint: Visual analog scale (VAS) for pain. Started Dec 2023; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2300078799.